U.S. markets open in 9 hours 20 minutes

Abbott India Limited (ABBOTINDIA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
18,801.00-116.55 (-0.62%)
As of 09:40AM IST. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close18,917.55
Bid18,813.75 x 0
Ask18,828.85 x 0
Day's Range18,800.00 - 19,045.85
52 Week Range15,514.00 - 23,934.45
Avg. Volume16,040
Market Cap399.508B
Beta (5Y Monthly)N/A
PE Ratio (TTM)50.02
EPS (TTM)375.86
Earnings DateN/A
Forward Dividend & Yield145.00 (0.71%)
Ex-Dividend DateAug 03, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ABBOTINDIA.NS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      Flu vaccine demand takes off in India as pandemic raises awareness

      A pandemic-spurred demand for flu vaccines in India has surged since a devastating second wave of COVID-19 brought the nation's healthcare system to its knees earlier this year. Vaccinations against influenza are not very common in India due to a lack of awareness, access and steep prices, and they are also not part of the federal government's universal immunization program that includes polio, tuberculosis and Hepatitis B. Still, more than 1,000 shots were administered at Manipal Hospital's sites in the tech hub of Bengaluru in southern India between July and September, compared with about 3,000 for all of last year, according to the healthcare provider.